The stentless temptation: drug-coated balloons between evidence, enthusiasm, and historical caution [0.03%]
无瓣膜的诱惑：药物涂层球囊在证据、热情和历史谨慎之间的选择
Andrea Mariani,Domenico Simone Castiello
Andrea Mariani
Physiology-guided percutaneous coronary intervention using drug-coated balloon versus drug-eluting stent: a propensity-matched analysis [0.03%]
基于生理学的药物涂层球囊与药物洗脱支架经皮冠状动脉介入治疗的倾向性匹配分析
Domenico Galante,Ciro Pollio Benvenuto,Simona Todisco et al.
Domenico Galante et al.
Background: Physiology-guided drug eluting stent percutaneous coronary intervention (ph DES-PCI) improves cardiovascular outcomes; however, the clinical benefit of ph drug coated balloon PCI (ph DCB-PCI) remains unclear. ...
When traditional risk fails: polygenic burden as the missing dimension in early coronary artery disease [0.03%]
传统风险失效时：早发动脉粥样硬化性疾病背景下遗传多态性负担的缺失环节
Annamaria Iorio,Giovanni Maria Severini
Annamaria Iorio
Polygenic risk in early-onset coronary artery disease with low prevalence of traditional cardiovascular risk factors [0.03%]
传统心血管危险因素低发的早发型冠心病中的多基因风险评分效应
Maddalena Rossi,Andrea Conti,Giulia Gagno et al.
Maddalena Rossi et al.
Aims: We aimed to investigate the potential role of polygenic risk in early-onset coronary artery disease (CAD) and recurrence of major adverse coronary events (MACE) in patients with low prevalence of traditional cardiov...
A hemodynamic and biomarker study of pulmonary hypertension associated with heart failure: DISCOVER PH-HF [0.03%]
与心脏病相关的肺动脉高压的血流动力学和生物标志物研究：DISCOVER PH-HF
Roberto Manni,Henri Xhakupi,Suela Vani et al.
Roberto Manni et al.
Aims: The pathogenesis of pulmonary hypertension associated with heart failure (PH-HF) is partially understood. To advance knowledge in this regard, the investigator-initiated, public-funded, prospective, translational st...
Desmin c.322G>A variant is associated with cardiomyopathy: a case series [0.03%]
DES基因c.322G>A变异与心肌病相关性分析：一系列病例研究
Giacomo Antonioli,Natascia Cerrato,Massimiliano Cecconi et al.
Giacomo Antonioli et al.
Background: Desmin is a critical intermediate filament protein in muscle cells that maintains myofibril integrity and proper force transmission. Rare variants in the DES gene are known to cause cardiomyopathy with or with...
BRASH syndrome: new mechanistic insights from contemporary cardiometabolic therapies [0.03%]
BRASH综合征：当代心血管代谢疗法带来新的机制见解
Lucio Giuseppe Granata,Simona Giubilato,Giuseppina Maura Francese et al.
Lucio Giuseppe Granata et al.
Watching the woods to prevent falling trees: do we need routine coronary computed tomography angiography surveillance after left main percutaneous coronary intervention? [0.03%]
防范于未然：左主干经皮冠状动脉介入治疗术后是否需要常规冠脉CT随访？
Ovidio De Filippo,Enrico Cerrato,Gianluca Campo et al.
Ovidio De Filippo et al.
Pregnancy in the broad phenotype and genotype spectrum of disease-causing desmosomal variant-positive women [0.03%]
心肌病致病性连接蛋白变异女性宽表型和基因型谱系中的妊娠问题
Silvia Castelletti,Annina S Vischer,Rachel Bastiaenen et al.
Silvia Castelletti et al.
Background: Pregnancy is generally well tolerated in patients with arrhythmogenic cardiomyopathy (AC), but there are limited data comparing right-dominant AC (ARVC) and left-dominant AC (ALVC), as well as gene-positive bu...
Eligibility for dual pathway inhibition in patients with peripheral artery disease undergoing revascularization [0.03%]
外周动脉疾病患者行血运重建术的双重通路抑制适应证
Antonio Greco,Claudio Laudani,Marco Spagnolo et al.
Antonio Greco et al.
Background: Dual pathway inhibition (DPI) with low-dose rivaroxaban and aspirin offers superior ischemic protection compared with single-agent therapy in patients with peripheral artery disease (PAD). However, its real-wo...